Literature DB >> 10993951

Differential effects of stromal derived factor-1 alpha (SDF-1 alpha) on early and late stages of human megakaryocytic development.

P Secchiero1, C Celeghini, G Cutroneo, A Di Baldassarre, R Rana, G Zauli.   

Abstract

Stromal derived factor-1 alpha (SDF-1 alpha), the high-affinity ligand of CXC-chemokine receptor 4 (CXCR4), was added to human CD34(+) hematopoietic progenitor cells that can be induced to differentiate along the monocytic or megakaryocytic lineages. In control liquid cell cultures supplemented with two different cytokine cocktails: stem cell factor (SCF), interleukin-3 (IL-3), macrophage-colony stimulating factor (M-CSF), and 10% fetal calf serum (FCS), or, SCF and thrombopoietin (TPO), the expression of surface CXCR4 progressively increased in both the CD14(+) monocytic and CD41(+) megakaryocytic lineages. While SDF-1 alpha caused only modest effects on cells of the monocytic lineage, it induced profound down-regulation of CXCR4 in megakaryocytic cells at all stages of differentiation. Moreover, while SDF-1 alpha initially up-regulated the early megakaryocytic antigen CD41, at later time points (days 12-16) it induced down-regulation of the late megakaryocytic antigen CD42b. Consistently, at day 16, the number of mature megakaryocytes was significantly decreased in cultures supplemented with SDF-1 alpha. These findings indicate that, besides its primary role in regulating the retention of precursor cells in hematopoietic tissues, the SDF-1 alpha/CXCR4 system participates in the regulation of megakaryocytic development by stimulating the formation of immature megakaryoblasts and inhibiting the formation of mature megakaryocytes. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993951     DOI: 10.1002/1097-0185(20001001)260:2<141::AID-AR40>3.0.CO;2-I

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  12 in total

Review 1.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

2.  MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12.

Authors:  Rongfeng Qu; Yan Sun; Yarong Li; Chunmei Hu; Guang Shi; Yan Tang; Dongrui Guo
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 3.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.

Authors:  Xueqing Sun; Guangcun Cheng; Mingang Hao; Jianghua Zheng; Xiaoming Zhou; Jian Zhang; Russell S Taichman; Kenneth J Pienta; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 4.  White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions.

Authors:  Achinto Saha; Jill Hamilton-Reeves; John DiGiovanni
Journal:  Cancer Metastasis Rev       Date:  2022-08-04       Impact factor: 9.237

5.  Bovine immunodeficiency virus expression in vitro is reduced in the presence of beta-chemokines, MIP-1alpha, MIP-1beta and RANTES.

Authors:  S M Wright; A Mleczko; K S Coats
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

6.  PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.

Authors:  M Katie Conley-LaComb; Allen Saliganan; Pridvi Kandagatla; Yong Q Chen; Michael L Cher; Sreenivasa R Chinni
Journal:  Mol Cancer       Date:  2013-07-31       Impact factor: 27.401

7.  SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease.

Authors:  Dominik Rath; Elke Schaeffeler; Stefan Winter; Jens Hewer; Karin Müller; Michal Droppa; Fabian Stimpfle; Meinrad Gawaz; Matthias Schwab; Tobias Geisler
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

8.  CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.

Authors:  Thomas A Werner; Christina M Forster; Levent Dizdar; Pablo E Verde; Katharina Raba; Matthias Schott; Wolfram T Knoefel; Andreas Krieg
Journal:  Br J Cancer       Date:  2017-11-07       Impact factor: 7.640

9.  CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma.

Authors:  Thomas Artur Werner; Christina Maria Forster; Levent Dizdar; Pablo Emilio Verde; Katharina Raba; Matthias Schott; Wolfram Trudo Knoefel; Andreas Krieg
Journal:  J Cancer       Date:  2018-02-27       Impact factor: 4.207

10.  Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.

Authors:  Jiachi Ma; Xiaowen Sun; Yimin Wang; Bangling Chen; Liyu Qian; Yaguo Wang
Journal:  Cell Commun Signal       Date:  2019-09-10       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.